About Mirari Doctor | FDA 510(k) Cleared Medical Device Manufacturer

Our Story

Mirari Doctor was established to bridge the gap between breakthrough medical technology and clinical practice. Our founding team brings together expertise from the semiconductor industry, international telecommunications, and biomedical engineering — united by a shared belief that advanced therapeutic tools should be accessible to patients worldwide.

Incorporated in Singapore, Mirari Doctor Pte. Ltd. operates as the authorized global commercialization partner of General Vibronics, Inc. — the U.S.-based developer and legal manufacturer of the MIRARI® Cold Plasma System, a Class II medical device platform.

Drawing on decades of research by General Vibronics into the medical applications of RF energy, the MIRARI® Cold Plasma System is a U.S.-patented handheld device designed to be powerful, durable, and immediately deployable in clinical settings.

Today, the MIRARI® platform holds FDA 510(k) clearance (K242553), Thai FDA approval, and Vietnam Ministry of Health registration — enabling healthcare professionals to deliver non-invasive therapy to patients across three continents.

Leadership

The team behind Mirari Doctor brings decades of experience in RF design, Dielectric Barrier Discharge (DBD), biomedical engineering and physics, and global medical device commercialization.

Huan Truong

CEO & Founder

Huan Truong is a technology entrepreneur, architect, and technical designer with deep expertise in electronic system design, mixed-signal silicon technologies, and advanced product development. He has built a career around transforming complex concepts into commercially viable innovations, with a strong track record in strategic leadership, manufacturing, and cross-functional execution.

As Founder and CEO of Mirari Doctor Inc., based in Chandler, Arizona, Huan has led the company since 2012, defining its long-term vision, directing product strategy, and overseeing the design and manufacturing of the MIRARI product line. His leadership spans research and development, operations, investor relations, and intellectual property strategy, helping position the company at the intersection of healthcare innovation and engineering excellence.

In 2023, Huan expanded this mission internationally as Founder and CEO of MIRARI DOCTOR PTE. LTD. in Singapore. In this role, he leads the company focuses on global market expansion, strategic partnerships, distribution agreements, and capital raising to accelerate adoption of the technology worldwide. Mirari Doctor is strategically positioned to access the rapidly growing healthcare markets across Asia while serving as a gateway for broader international commercialization. In parallel, the software and database components of the MIRARI® system are developed, owned, and managed by ChiScan Holdings Pte. Ltd. and IOLera Holdings Pte. Ltd., with exclusive licensed rights granted to MIRARI DOCTOR under a separate but complementary licensing framework. This digital portfolio includes the design, development, deployment, and maintenance of a wide range of software applications and data management systems, including mobile and web-based applications, backend database infrastructure, Scanlog databases and related data protocols, instructional datasets, system logic, and analytical tools supported by Artificial Intelligence (AI) frameworks, toolkits, and Application Programming Interfaces (APIs), as well as components integrated into decentralized blockchain ecosystems and other supporting digital assets that enhance the delivery and long-term evolution of cold plasma medical technologies. He also drives the company’s broader vision of combining therapeutic innovation with mobile health applications to empower patients with more accessible and personalized care solutions.

Huan is recognized for his ability to combine visionary strategy with technical depth. His strengths include innovation leadership, team building, electronic application system design, and end-to-end manufacturing and production. He has successfully built and led high-performing teams while guiding products from concept through fabrication and market execution.

He holds a Master of Science in Electrical Engineering and a Bachelor of Science in Electrical Engineering from Arizona State University, as well as an Associate of Science in Electrical Engineering from Broome Community College.

Throughout his career, Huan has contributed extensively to scientific and technical advancement through award-winning poster presentations, conference participation, and published proceedings in areas including cold plasma technology, antimicrobial applications, water decontamination, and electromagnetic modulation. He is also a prolific inventor, holding 27 granted patents worldwide and 15 pending patents

Alyssa Flores

Chief Commercialization Officer (CCO)

Alyssa Flores is a senior commercial executive known for building and scaling revenue platforms for emerging and growth-stage medical technologies. With a strong foundation in high-performance medical sales and market access, she has consistently transformed early-stage innovations into commercially viable, revenue-generating businesses.

As Chief Commercial Officer, Alyssa leads enterprise-level commercialization strategy across the United States, with direct oversight of distribution architecture, channel expansion, and strategic partnerships. Her expertise spans durable medical equipment (DME), hospital systems, group purchasing organizations (GPOs), and government contracting—where she has successfully penetrated complex, high-barrier markets and established defensible revenue channels.

Alyssa is particularly recognized for structuring and executing high-impact commercial frameworks, including exclusive distribution models, government and institutional access strategies, and scalable go-to-market systems. She brings a disciplined approach to aligning clinical value with reimbursement pathways, ensuring that innovation translates into sustainable, repeatable revenue.

Her experience includes launching and scaling advanced wound care, biologics, and AI-driven technologies, with a focus on accelerating adoption while optimizing margin and long-term market positioning. She operates at the intersection of strategy and execution—building infrastructure that supports rapid growth while maintaining control over key revenue streams.

In addition to her executive leadership, Alyssa serves as a strategic advisor to medtech founders and investors, guiding commercialization strategy, deal structuring, and U.S. market entry. She is frequently engaged in opportunities where strong commercial leadership is required to unlock valuation and drive scale.

Alyssa is known for her decisive leadership style, sharp negotiation strategy, and ability to create alignment across stakeholders—consistently delivering results in competitive and complex healthcare environments.

Benjamin Tietgen

General IP counsel

Brad Eckert

Co-Founder - Scientist

Bryon Eckert

Co-Founder - Scientist

Mission Statement

We commercialize regulatory-cleared, medical-grade RF energy solutions. We ensure market access by securing the required regulatory clearances in each jurisdiction prior to commercialization. We train, equip, and support our clinical and distribution partners, so they can deliver better care.

Vision Statement

A world where FDA-cleared RF energy therapy is a recognized standard of clinical care — improving patient outcomes across every healthcare system, in every market.

What Drives Us

Scientific Rigor

Every decision we make, from product design to clinical application, is grounded in peer-reviewed science and validated evidence.

Regulatory Integrity

We pursue the highest regulatory standards across every market we enter. Compliance is not a checkbox, it is foundational to our identity.

Partnership First

We succeed when our partners succeed. We invest in clinical training, regulatory support, and long-term relationships, not transactional sales.

Global Access

Advanced medical technology should not be limited by geography. We are committed to making MIRARI® available to healthcare systems worldwide.

Quality & Manufacturing Standards

Every MIRARI® device is produced under a Quality Management System that meets the most demanding international standards for medical device manufacturing.

ISO 13485:2016

Medical Device Quality Management

FDA 21 CFR Part 820

Quality System Regulation

Patents

Developed over years of dedicated research, our granted U.S. patents represent the intellectual foundation of MIRARI® — protecting innovations that took decades of scientific expertise to achieve.

Conferences & Presentations

Mirari Doctor has presented at leading scientific, defense, and medical device conferences, bringing cold plasma innovation to the forefront of global healthcare discussion.

Defense Energy Innovation Summit & Showcase

Austin, TX | December 1-3, 2015

ASM Biodefense & Emerging Diseases Research Meeting

Arlington, VA | February 8-10, 2016

SAWC Spring - Symposium on Advanced Wound Care & Wound Healing Society

Atlanta, GA | April 13-17, 2016

TechConnect World Innovation Conference & Expo

Washington, DC | May 22-25, 2016

Who We Are